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OBJECTIVES: The goal of this study was to evaluate the relationship between serum albumin levels and 24-hour
ambulatory blood pressure monitoring (24-h ABPM) recordings in non-diabetic essential hypertensive patients.
METHODS: A total of 354 patients (mean [SD] age: 55.5 [14.3] years, 50% females) with essential hypertension
and 24-h ABPM recordings were included. Patient 24-h nighttime and daytime ABPM values, systolic and
diastolic dipping status and average nocturnal dipping were recorded. The correlations between serum albumin
levels and nocturnal systolic and diastolic dipping were evaluated, and correlates of average nocturnal systolic
dipping were determined via a linear regression model.
RESULTS: Overall, 73.2% of patients were determined to be non-dippers. The mean (SD) levels of serum albumin
(4.2 [0.3] g/dL vs. 4.4 [0.4] g/dL, po0.001) and the average nocturnal systolic (15.2 [4.8] mmHg vs. 0.3 [6.6] mmHg,
po0.001) and diastolic dipping (4.2 [8.6] mmHg vs. 18.9 [7.0] mmHg, po0.001) were significantly lower in non-
dippers than in dippers. A significant positive correlation was noted between serum albumin levels and both systolic
(r=0.297, po0.001) and diastolic dipping (r=0.265, po0.001). The linear regression analysis revealed that for each
one-unit increase in serum albumin, the average nocturnal dip in systolic BP increased by 0.17 mmHg (p=0.033).
CONCLUSION: Our findings indicate an association between serum albumin levels and the deterioration of
circadian BP rhythm among essential hypertensive patients along with the identification of a non-dipper
pattern in more than two-thirds of patients. Our findings emphasize the importance of serum albumin levels,
rather than urinary albumin excretion, as an independent predictor of nocturnal systolic dipping, at least in
non-diabetic essential hypertensive patients with moderate proteinuria.
KEYWORDS: Hypertension; Serum Albumin; Ambulatory Blood Pressure; Dipping Status; Nocturnal Blood Pressure.
Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T, et al. The relationship between serum albumin levels and 24-h ambulatory blood
pressure monitoring recordings in non-diabetic essential hypertensive patients. Clinics. 2016;71(5):257-263
Received for publication on November 27, 2015; First review completed on January 13, 2016; Accepted for publication on February 11,
2016
*Corresponding author. E-mail: karaekrem79@hotmail.com
’ INTRODUCTION
Deterioration of the circadian blood pressure (BP) rhythm,
particularly a non-dipper circadian BP pattern, represents a risk
factor for target organ damage and worsening of cardiovascular
and renal parameters in patients with essential hypertension (1,2).
Ambulatory BP monitoring (ABPM), which provides data regarding
changes in BP during daily activities (3), has been considered superior to
officemeasurements of BP becauseABPM identifies nocturnal declines in
BP levels and has higher consistency with target organ damage, thus
predicting cardiovascular morbidity and mortality (4-8).
The limited amount of available data regarding the association
between serum albumin levels and circadian BP rhythm indicates a
correlation between less BP dipping and low serum albumin levels
among the elderly (9), hemodialysis patients (10), patients with
chronic kidney disease (CKD) (11,12) and hypertensive-naïve or
nephrotic, non-diabetic patients (13). Notably, the sodium retention
and high sodium sensitivity caused by impaired daytime
natriuresis have been shown to be associated with a loss of
nocturnal decline in BP among patients with essential hypertension
to provide compensatory pressure natriuresis during the nighttime
(14-17). Moreover, the mechanism underlying the relationship
between serum albumin and nighttime BP decline, the crucialDOI: 10.6061/clinics/2016(05)03
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predictor of cardiovascular events through vascular atherosclerosis,
has not yet been elucidated (9).
Similarly, although numerous recent studies have focused
on the relationship between urinary albumin excretion
(UAE) and the loss of nocturnal BP decline, which are two
notable risk markers of cardiovascular mortality and
morbidity as well as end-stage CKD in hypertensive patients
(13,18,19), it remains unclear whether albuminuria is a cause
or a consequence of impaired circadian BP rhythm (13).
Moreover, given the inverse relationship between serum
and urinary albumin levels, the presence of albuminuria
concomitant with a loss of nighttime BP decline has been
found to inevitably cause hypoalbuminemia in patients with
non-diabetic nephropathy or glomerulonephritis (13). There-
fore, the present study was designed to evaluate the
relationship between serum albumin levels and 24-h ABPM
recordings in non-diabetic essential hypertensive patients.
’ MATERIALS AND METHODS
Study population
This retrospective single-center study included 354
patients (mean [SD] age: 55.5 [14.3] years, 50% females)
with a diagnosis of essential hypertension who received
follow-up care, including 24-h ABPM recordings, at our
clinic between 2013 and 2015. The patients were divided into
4 groups based on serum albumin levels: quartile 1 (Q1; serum
albumin o4.1 g/dL), quartile 2 (Q2; serum albumin X4.1o4.4
g/dL), quartile 3 (Q3; serum albumin X4.4o4.6 g/dL) and
quartile 4 (Q4; serum albumin X4.6 g/dL).
Patientswith thyroid function disorders, secondary hypertension,
diabetes mellitus, chronic liver disease, acute infection or sleep
disorders were excluded from the study.
The study was conducted in full accordance with local Good
Clinical Practice (GCP) Guidelines and current legislation, and
permission for the use of patient data for publication purposes
was obtained from our institutional ethics committee.
Study parameters
Data regarding patient demographics, body mass
index (BMI; kg/m2), antihypertensive medication history,
urinalysis (proteinuria [gr/24 h]) and blood biochemistry
findings (urea [mg/dL]; creatinine [mg/dL]; e-GFR [mL/
min], uric acid [mg/dL], sodium [mmol/L], potassium [mmol/
L], calcium [mg/dL], phosphorus [mg/dL], CaxP product,
intact parathormone [PTH; pg/mL], hemoglobin [g/dL], total
cholesterol [mg/dL], triglycerides [mg/dL], low-density lipo-
protein cholesterol [LDL-c; mg/dL], high-density lipoprotein
cholesterol [HDL-c; mg/dL], albumin [g/dL] and ferritin [ng/
mL]) were obtained from the medical records of each patient.
The 24-h, nighttime and daytime ABPM values of systolic and
diastolic BP; systolic and diastolic dipping status (% of dippers
and non-dippers); and average amount of nocturnal dipping
were recorded in all patients. Blood biochemistry findings, BMI
and antihypertensive treatment were evaluated with respect to
dipping status (dippers vs. non-dippers), whereas 24-h ABPM
recording and average nocturnal dipping were evaluated with
respect to quartiles of serum albumin levels (Q1-4) and dipping
status. The correlation between serum albumin levels and
nocturnal systolic and diastolic dipping was evaluated, and
correlates of average nocturnal systolic dipping were deter-
mined via a linear regression model with age; serum levels of
albumin, creatinine and hemoglobin; and 24-h urinary protein
levels as the variables.
Serum albumin levels were measured with an ECLIA test
performed using a Cobas E601 analyzer (Roche Diagnostics,
MA, USA).
ABPM recordings
A portable noninvasive recording device (Model 90217A-
1, Spacelabs, Hertford, United Kingdom) was used to record
24-h ABPM values. All patients were graded according to
overall, nighttime and daytime systolic and diastolic BP
levels. The 24-h ABPM values were obtained via BP readings
set at 20-minute intervals (06:00 AM – 24:00 PM) and at 30-
minute intervals (24:00 PM – 06:00 AM). The patients were
asked to continue with their normal daily routine and to
record the times at which they went to sleep and awakened.
The data were transferred to a computer and loaded into
ABPM report management system software for the final
analysis using the ABPM-FIT program (University of
Heidelberg, Germany, version 2.2). For each 24-h measure-
ment, the mean systolic and diastolic BP levels were
evaluated separately for the daytime and nighttime periods.
Daytime and nighttime arterial hypertension were diagnosed
according to the ESH/ESC guidelines (20) (daytime: systolic
BPX140 mmHg and/or diastolic BPX90 mmHg; nighttime:
systolic BP 4120 mmHg and diastolic BP 470 mmHg). The
non-dominant arm was the site of cuff placement for ABPM.
The ambulatory monitor had to agree with a mercury
column sphygmomanometer to within 7 mmHg, and
patients with failure of X25% of BP recordings on a daily
basis were not included in the final analysis.
Definitions of dippers and non-dippers
Time in bed was measured based on a diary maintained by the
patients that documented the exact times of getting into and
arising from bed. The average BP for the time in bed (termed
nighttime BP) was calculated from the ambulatory monitoring
data. The daytime BP was defined as the BP during the
remainder of the 24-h period. The percentage decline in the
nighttime BPwas calculated as follows: 100 X (1 - mean nighttime
systolic BP /mean daytime systolic BP). Patients with a decline in
nighttime BP of less than 10% were considered non-dippers (7).
Statistical analysis
The statistical analysis was performed using IBM SPSS
Statistics (IBM Corp. Released 2012, IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY: IBM Corp). A Chi-
square (w2) test was used for comparisons of categorical data.
Student’s t-test was used for the analysis of parametric
variables. Comparisons of albumin quartile groups were per-
formed via one-way ANOVA. Spearman’s correlation ana-
lysis was performed to determine the relationship between
serum albumin levels and dipping status, and correlates of
average nocturnal systolic dipping were determined via a
linear regression model with age; serum levels of albumin,
creatinine and hemoglobin; and 24-h urinary protein levels
as the variables. The data were expressed as the means (SD),
percentages (%) and 95% confidence intervals (CIs), as
appropriate. Po0.05 was considered statistically significant.
’ RESULTS
Baseline characteristics and 24-h ABPM recordings
in dippers vs. non-dippers
Among the 354 patients, 95 (26.8%) were determined to be
dippers, and 259 (73.2%) were non-dippers. No significant
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differences were noted between the dippers and non-dippers
in terms of patient characteristics, BMI, antihypertensive
medication or overall 24-h or daytime systolic and diastolic
ABPM recordings. Compared with dippers, the non-dippers
had significantly higher mean (SD) nighttime systolic (152.3
[23.9] mmHg vs. 130.8 [17.6] mmHg, po0.001) and diastolic
BP (82.3 [15.9] mmHg vs. 71.8 [11.7] mmHg, po0.001),
whereas they had significantly lower average nocturnal
systolic (0.3 [6.6] mmHg vs. 15.2 [4.8] mmHg, po0.001) and
diastolic dipping (4.2 [8.6] mmHg vs. 18.9 [7.0] mmHg,
po0.001) (Table 1).
Compared with dippers, the non-dippers had significantly
lower mean (SD) serum albumin levels (4.2 [0.3] vs. 4.4 [0.4]
g/dL, po0.001); otherwise, the two groups had similar
laboratory results, including proteinuria (Table 2).
24-h ABPM recordings according to quartiles of
serum albumin levels
The serum albumin quartiles Q1, Q2, Q3 and Q4 included
71 (20.1%), 100 (28.2%), 78 (22.0%) and 105 (29.7%) patients,
respectively. Compared to the patients in Q1, the ABPM
recordings of the other groups revealed significantly lower
values as follows: mean (SD) 24-h systolic BP in Q2 (157.8
[19.0] mmHg vs. 148.7 [19.6] mmHg, po0.005) and Q4 (157.8
[19.0] mmHg vs. 149.6 [20.0] mmHg, po0.05); 24-h diastolic
BP in Q2 (89.1 [15.2] mmHg vs. 81.6 [11.5], po0.01); daytime
diastolic BP in Q2 (89.8 [15.1] mmHg vs. 83.3 [12.0] mmHg,
po0.05); nighttime systolic BP in Q2, Q3 and Q4 (158.6 [23.1]
mmHg vs. 143.8 [22.5] mmHg, 145.7 [27.9] mmHg and 141.3
[21.6] mmHg, respectively; po0.001 for each); and nighttime
diastolic BP in Q2, Q3 and Q4 (87.0 [17.5] mmHg vs.
Table 1 - Baseline characteristics and 24-h ambulatory blood pressure monitoring recordings in dippers vs. non-dippers.
Patient characteristics Dippers (n=95) Non-dippers (n=259) p valuea
Age (years), mean (SD) 53.4 (15.5) 56.3 (13.8) 0.092
Gender (M/F) 47/48 130/129 1.000
BMI (kg/m2), mean (SD) 30.9 (4.8) 30.1 (5.7) 0.554
Antihypertensive medication % %
ACE inhibitor 36.7 33.3 0.687
Angiotensin receptor blocker 32.6 28.8 0.547
Beta-blocker 18.4 16.8 0.773
Calcium channel blocker 12.6 16.4 0.476
Diuretics 21.3 19.8 0.871
24-h ABPM recordings (mmHg) Mean (SD) Mean (SD)
Overall
24-h systolic BP 148.2 (20.1) 152.6 (20.9) 0.078
24-h diastolic BP 84.6 (13.1) 85.0 (14.8) 0.822
Daytime
Systolic BP 154.1 (20.7) 152.7 (20.5) 0.590
Diastolic BP 89.0 (13.9) 85.8 (15.0) 0.077
Nighttime
Systolic BP 130.8 (17.6) 152.3 (23.9) o0.001
Diastolic BP 71.8 (11.7) 82.3 (15.9) o0.001
Average nocturnal dipping
Systolic 15.2 (4.8) 0.3 (6.6) o0.001
Diastolic 18.9 (7.0) 4.2 (8.6) o0.001
ABPM: ambulatory blood pressure monitoring; ACE: angiotensin-converting enzyme; BP: blood pressure; BMI: body mass index.
aChi-square (w2) test, bStudent’s t-test
Table 2 - Laboratory findings in dipper and non-dipper patients.
Dippers (n=95) Non-dippers (n=259)
Laboratory parameter Mean (SD) Mean (SD) p valuea
Urea (mg/dL) 50.3 (33.2) 55.8 (36.1) 0.153
Creatinine (mg/dL) 1.49 (1.16) 1.75 (1.67) 0.167
e-GFR (mL/min/1.73m2) 62.1 (34.1) 56.0 (35.3) 0.557
Uric acid (mg/dL) 5.9 (1.6) 6.2 (1.6) 0.268
Sodium (mmol/L) 139.5 (3.6) 139.8 (3.1) 0.429
Potassium (mmol/L) 4.5 (0.5) 4.7 (0.5) 0.070
Calcium (mg/dL) 9.4 (0.5) 9.3 (0.5) 0.054
Phosphorus (mg/dL) 3.7 (0.8) 3.6 (0.8) 0.917
CaxP product 34.7 (7.9) 34.2 (7.1) 0.590
Intact PTH (pg/mL) 97.0 (88.3) 110.2 (106.3) 0.413
Hemoglobin (g/dL) 13.3 (1.8) 13.0 (1.9) 0.153
Total cholesterol (mg/dL) 202.0 (39.8) 201.6 (44.8) 0.943
Triglycerides (mg/dL) 149.3 (76.0) 171.4 (131.5) 0.163
LDL-cholesterol (mg/dL) 118.7 (37.8) 120.9 (39.6) 0.674
HDL-cholesterol (mg/dL) 51.1 (19.5) 51.7 (52.1) 0.927
Albumin (g/dL) 4.4 (0.4) 4.2 (0.3) o0.001
Ferritin (ng/mL) 135.8 (211.0) 113.1 (127.6) 0.279
Proteinuria (gr/24 h) 0.79 (1.15) 1.13 (1.82) 0.091
CaxP: calcium x phosphorus; e-GFR: estimated glomerular filtration rate; HDL: high-density lipoprotein; LDL: low-density lipoprotein; PTH: parathormone.
aDipper vs. non-dipper; Student’s t-test
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76.0 [12.1] mmHg, 78.6 [16.4] mmHg and 78.3 [15.0] mmHg,
respectively; po0.001 for each) (Table 3).
Average nocturnal systolic and diastolic dipping
according to quartiles of serum albumin levels
Compared with the patients in serum albumin quartile Q1,
the patients in Q3 and Q4 had significantly higher mean (SD)
nocturnal systolic dipping (-0.36 [8.42] mmHg vs. 4.79 [9.89]
mmHg and 7.16 [8.78] mmHg, respectively; po0.001 for
each), and the patients in Q4 had significantly higher
nocturnal diastolic dipping (3.48 [10.32] mmHg vs. 11.14
[10.25] mmHg, po0.01) (Table 4, Figure 1).
Correlation between serum albumin levels and
nocturnal dipping
Significant positive correlations were noted between serum
albumin levels and both systolic (r=0.297, po0.001) and
diastolic dipping (r=0.265, po0.001) (Table 5 and Figure 2).
Linear regression analysis of correlates of average
nocturnal systolic dipping
The linear regression analysis revealed that for each one-
unit increase in serum albumin, the average nocturnal dip in
systolic BP increased by 0.17 mmHg (p=0.033), even after
adjustments for age, serum creatinine, serum hemoglobin
and 24-h urinary protein levels (Table 6).
’ DISCUSSION
Our findings in a retrospective cohort of essential
hypertensive patients revealed lower serum albumin levels
in non-dippers than dippers. Moreover, lower average noct-
urnal dipping and thus higher nocturnal systolic and
diastolic ABPM values were observed in patients with lower
(o4.1 g/dL) serum albumin levels. Along with the positive
correlation between albumin levels and average nocturnal
systolic and diastolic dipping, a decrease in serum albumin
was shown to be an independent predictor of lower average
nocturnal systolic dipping.
The association between serum albumin levels and the loss
of nocturnal BP decline has been reported in several studies
of elderly patients (9), hemodialysis patients (10), patients
with CKD (11,12) and hypertensive-naïve or nephrotic non-
diabetic patients (13).
A previous study of the effects of nutritional parameters
on nocturnal BP in Turkish hemodialysis patients revealed an
association between malnutrition and deterioration in the
circadian BP rhythm (10). The malnutrition score was
positively correlated with nighttime systolic BP, mean
nighttime BP and mean 24-h arterial BP as well as with
reductions in serum albumin and anthropometric indices
(10). Therefore, low serum albumin levels and hypervolemia
have been suggested to contribute to the association between
impaired nutritional status and elevated nighttime BP (10).
In another study of 778 subjects including hypertensive
naïve non-diabetic subjects (n=231), subjects without protei-
nuria (n=441) and non-diabetic nephrotic patients (n=37),
Table 3 - 24-h Ambulatory blood pressure monitoring recordings according to quartiles of serum albumin levels.
ABPM recordings
Overall-24 h Daytime (mmHg) Nighttime (mmHg)
Serum albumin
levels
Systolic BP Diastolic BP Systolic BP Diastolic BP Systolic BP Diastolic BP
Albumin quartiles Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Q1 (n=71) 3.6(0.5) 157.8(19.0) 89.1(15.2) 157.6(18.7) 89.8(15.1) 158.6(23.1) 87.0(17.5)
Q2 (n=100) 4.2(0.1)*** 148.7(19.6)* 81.6(11.5)** 150.5(19.3) 83.3(12.0)* 143.8(22.5)*** 76.0(12.1)***
Q3 (n=78) 4.4(0.2)*** 151.5(23.8) 83.9(15.7) 153.1(23.2) 85.7(16.1) 145.7(27.9)*** 78.6(16.4)***
Q4 (n=105) 4.7(0.1)*** 149.6(20.0)* 85.8(14.6) 152.5(20.5) 88.5(15.3) 141.3(21.6) *** 78.3(15.0)***
BP: blood pressure; SD: standard deviation; Q: quartile
Q1: serum albumin o4.1 g/dL
Q2: serum albumin X4.1o4.4 g/dL
Q3: serum albumin X4.4o4.6 g/dL
Q4: serum albumin X4.6 g/dL
*po0.05,**po0.01 and ***po0.001 compared to Q1; ANOVA and post-hoc Tukey tests
Table 4 - Average nocturnal systolic and diastolic dipping
according to quartiles of serum albumin levels.
Albumin
quartiles
Nocturnal dipping, mean (SD)
Systolic Diastolic
Q1 (n=71) -0.36(8.42) 3.48(10.32)
Q2 (n=100) 4.44(7.80) 8.52(10.12)
Q3(n=78) 4.79(9.89)** 8.20(9.96)
Q4 (n=105) 7.16(8.78)** 11.14(10.25)*
Q: quartile; Q1: serum albumin o4.1 g/dL; Q2: serum albumin X4.1o4.4
g/dL; Q3: serum albumin X4.4o4.6 g/dL; Q4: serum albumin X4.6 g/dL.
*po0.01 and **po0.001 compared to Q1; ANOVA and post-hoc Tukey
tests
Figure 1 - Average nocturnal dipping according to quartiles of
serum albumin levels. Q1: serum albumin o4.1 g/dL; Q2: serum
albumin X4.1o4.4 g/dL; Q3: serum albumin X4.4o4.6 g/dL;
Q4: serum albumin X4.6 g/dL.
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nighttime BP decline was found to be associated with marked
changes in both urinary and serum albumin levels (13).
In our study population, non-dipping status was asso-
ciated with significantly lower serum albumin compared
with dipping status and low albumin levels predicted lower
average nocturnal systolic dipping. However, no significant
correlation was noted between the amount of proteinuria
and dipping status and moderate proteinuria was evident in
both dipper and non-dipper hypertensive patients.
Serum albumin has been reported to be an independent
predictor of loss of nocturnal BP decline even in subjects with
no albuminuria or dipstick-positive proteinuria (13). In non-
diabetic subjects, a significant loss of nighttime BP decline
preceding the emergence of massive albuminuria and
hypoalbuminemia was normalized following the correction
of hyperalbuminuria and hypoalbuminemia (13).
Given that hyperalbuminuria and hypoalbuminemia are
inseparable and usually coexisting conditions, it has been
considered difficult to evaluate the relationship between
serum albumin levels and circadian BP patterns without
considering albuminuria (13). Our findings indicate that
serum albumin levels, rather than albuminuria, are a signif-
icant determinant of nighttime BP decline, at least among
non-diabetic essential hypertensive patients with moderate
proteinuria. Similarly, an increase in serum albumin to43 g/dL
was reported to be associated with a significant decrease in
sleeping/waking mean BP in non-diabetic nephrotic patients,
whereas lowering urinary albumin/creatinine to o300 mg/g
was shown to be ineffective (13).
Notably, a disrupted 24-h BP rhythm has been suggested
to precede microalbuminuria, whereas it is considered
unlikely that microalbuminuria predisposes a patient to
pathophysiological alterations that lead to a loss of nocturnal
BP decline per se (13). These findings imply a potential
impact of a greater burden of long-term traditional cardio-
vascular risk factors, at least in non-diabetic hypertensive
patients (13).
In fact, a non-dipper circadian BP pattern was shown to be
associated with subsequent microalbuminuria (2,21), which
is a well-recognized marker of adverse cardiovascular
outcomes in hypertensive subjects (22,23). Moreover, a close
relationship between a diurnal rhythm of BP and albumin
excretion has been suggested in patients with essential
hypertension (21).
Sodium retention and high sodium sensitivity were
reported to cause a loss of nocturnal BP decline among
patients with essential hypertension (15,16). Impaired day-
time natriuresis has been suggested to be associated with
elevations in nocturnal BP to facilitate pressure natriuresis
and thus to compensate for the diminished natriuresis
during the day (14,16,17). In this regard, given the associa-
tion between hypoalbuminemia and low plasma oncotic
pressure and shifting of sodium and fluid from the
intravascular circulation to the extravascular space (14), the
lower serum albumin levels among non-dipper compared
with dipper patients in our study might also be associated
with compensatory natriuresis.
However, although 73.0% of the hypertensive patients in
our cohort were non-dippers, moderate proteinuria was
evident regardless of dipping status.
Nonetheless, it should be noted that a debate continues
regarding the common pathogenic mechanisms between
UAE and circadian BP, with inconsistent findings regarding
the role of a non-dipping pattern in the appearance of
unfavorable UAE and regarding the value of absolute BP
levels or dipping/non-dipping status in predicting UAE (21).
As an independent predictor of diabetic nephropathy and
impaired renal function (24) and an indicator of inflamma-
tory process of atherogenesis via its negative correlation with
C-reactive protein levels (25), low serum albumin has been
considered to play a key role in systemic vascular damage
(13). Hypoalbuminemia, even a decrease of only 0.2 g/dL,
has been suggested to be closely associated with an increased
risk of cardiovascular events (26,27).
The significantly lower nighttime systolic and diastolic BP
in the Q2, Q3 and Q4 serum albumin quartiles in our cohort
suggest that a decline in albumin levels beyond 4.1 g/dL
appears to increase the likelihood of non-dipping status in
patients with essential hypertension.
A decrease in serum albumin was shown to be an
independent predictor of lower average nocturnal systolic
dipping and thus a nocturnal systolic non-dipping pattern, in
our cohort. This finding appears to agree with reports that
Table 5 - Correlations between serum albumin levels and
nocturnal dipping.
Albumin Systolic
dipping
Diastolic
dipping
Albumin N 354 354 354
r 1.000 0.297 0.265
p - o0.001 o0.001
Systolic dipping N 354 354 354
r 0.297 1.000 0.831
p o0.001 - o0.001
Diastolic dipping N 354 354 354
r 0.265 0.831 1.000
p o0.001 o0.001 -
Spearman’s correlation analysis; r=correlation coefficient.
Bold values indicate correlations significant at the 0.01 level (2-tailed).
Figure 2 - Receiver operating characteristic-curve analysis for
sensitivity, specificity and cut-off values of the relationship
between serum albumin levels and systolic dipping.
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nighttime BP is more closely associated with the albumin-to-
creatinine ratio (ACR) compared with daytime and 24-h BP (13).
Loss of nighttime BP decline has been shown to be a crucial
risk marker for vascular atherosclerosis and cardiovascular
events and an independent risk factor for overt CV disease
(13,28-30). Along with the superiority of systolic over diastolic
BP non-dipping in the prediction of target organ damage in
essential hypertension (31), hypertensive nocturnal dippers
were reported to exhibit a worse profile than normotensives
regarding pulse wave velocity, ACR and hs-CRP (32). The
identification of serum albumin levels as an independent
predictor of nocturnal systolic non-dipping in our cohort
supports the idea that serum albumin levels alone may
provide sufficient data on systolic non-dipping and, thus,
indices of target organ damage and cardiovascular risk (13,31).
Certain limitations of this study should be considered.
First, due to the retrospective single-center design, establish-
ing temporality between cause and effect and generalizing
our findings to the overall essential hypertensive population
may be difficult. Second, although no significant association
was noted between dipping status and the type of
hypertensive agents used by patients, we cannot exclude
the possibility that the maintenance of treatment during
ABPM altered the relationship between BP and the study
outcomes. The limited data on surrogate markers of target
organ damage and cardiovascular risk in hypertensive
subjects is another limitation; the availability of such markers
would extend the knowledge achieved in the current study.
Despite these limitations, given the paucity of solid
information available in this area, our findings represent a
valuable contribution to the literature.
In conclusion, our findings indicate an association between
serum albumin levels and the deterioration of circadian BP
rhythm among essential hypertensive patients, with a non-
dipper pattern identified in more than two-thirds of the
patients. Our findings emphasize the importance of serum
albumin levels, rather than UAE, as an independent
predictor of nocturnal systolic dipping, at least in non-
diabetic essential hypertensive patients with moderate
proteinuria. Larger prospective ABPM studies addressing
the relationship between circadian BP rhythm and serum
and urinary albumin among hypertensive patients with
massive albuminuria or hypoalbuminemia are needed, as are
advanced biochemical markers of target organ damage and
cardiovascular risk.
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